Lord of Hatred may finally make good on the Mephisto arc of Diablo 4's campaign, which started in the original game and carried through Vessel of Hatred.

LS Cable & System Ltd. ("LS C&S"), a global leader in power and communication cable and system solutions, today announced plans for a significant additional investment in Chesapeake, Virginia.

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...

The 2025 Kia Niro Hybrid lineup starts at $28,435 for the LX and stretches up to $42,235 for the fully optioned SX Touring PHEV. It’s not the cheapest SUV in the class, but the value is obvious once ...

Acadia Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved DAYBUE® STIX (trofinetide) for oral solution, a dye- and preservative-free powder formulation ...

An Exploration of the Paths to Integrating Wu Opera into Moral Education in Primary School within the Framework Integration In response to the current problems in moral education in primary schools, ...

If the universe is expanding at the speed of light, what exists beyond the edge it hasn’t reached yet? During junior high ...

Children First Family Law today announced the publication of a new educational resource offering an in-depth look at the most common factors that influence custody decisions in Colorado family court.

Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for AKEEGA® (niraparib and abiraterone acetate ...

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...

This busy time of year didn't keep nearly 3,000 athletes away from taking part in one of more than 12 CLASH Endurance events ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...